poisar

Stocks · News reference

Arbutus Biopharma Announces FDA Lifts Clinical Hold on AB-101

Fiscal.ai

Arbutus Biopharma Corporation has been notified by the U.S. Food and Drug Administration that the clinical hold on its Investigational New Drug application for AB-101 has been removed.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
fiscal.ai
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading